Pulmonx Corp
LUNG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$129.06M
Close$
$6.11
136.8% upside
Current Fair Value
136.8% upsideUndervalued by 136.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $129.06 Million |
|---|---|
| Enterprise Value | $129.71 Million |
| Earnings per Share | $-1.33 |
| Beta | 0.28 |
| Outstanding Shares | 43,176,913 |
Return
| Return on Equity | -108.56% |
|---|---|
| Return on Assets | -37.09% |
| Return on Invested Capital | -40.89% |
Valuation & Multiples
| P/E Ratio | -3.01 |
|---|---|
| PEG | 7.54 |
| Price to Sales | 1.29 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.46 |
| Enterprise Value to EBIT | -3.36 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | 1.44 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 27, 2026
EPS Estimate
$-0.26
Consensus analyst estimateRevenue Estimate
$21.93 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.26
Consensus analyst estimateRevenue Estimate
$21.93 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 712.33% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 62.13% |
|---|---|
| Total Invested | $178▼ 100.00% |
| Investors Holding | 3▼ 109.00% |
About Pulmonx Corp
220 employees
Pulmonx Corporation is a commercial-stage medical technology company. The Company is focused on providing planning tools and treatments for obstructive lung disease. Its solutions include Zephyr Valve, Chartis Pulmonary Assessment System...